Clinical Trial Update: Validation of TAD in HER-2 with More Than 2 Lymph Nodes

View source ↗

Summary

A clinical trial update notes the validation of TAD in HER2-positive breast cancer patients with more than two involved lymph nodes; the study is currently enro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia | Conditions: Breast Carcinoma Metastatic in Lymph Node, HER2 Positive Breast Carcinoma | Status: ENROLLING_BY_INVITATION